Poster 133 Percutaneous Peripheral Nerve Field Stimulation Therapy for Abdominal Wall Complex Regional Pain Syndrome: A Case Report

Chronic pain attributed to the abdominal wall is seen in 10-30% of patients who present to specialist pain clinics [24]. The most common cause is abdominal cutaneous nerve entrapment syndrome (ACNES). Trauma, including surgical incisions and tissue scarring, are well accepted causes of cutaneous nerve entrapment causing neuropathic pain [24]. The occurrence of peristomal neuropathic pain associated with an ileal-conduit formation is rare. A case of chronic cutaneous peristomal pain of the abdominal wall, refractory to conventional pharmacological therapies is described. The technique of peripheral nerve field stimulation (PNFS) for the successful management of peristomal neuropathic abdominal wall pain is reported.

Download Full-text

The Added Value of Subcutaneous Peripheral Nerve Field Stimulation Combined with SCS, as Salvage Therapy, for Refractory Low Back Pain Component in Persistent Spinal Pain Syndrome Implanted Patients: A Randomized Controlled Study (CUMPNS Study) Based on 3D-Mapping Composite Pain Assessment

10.20944/preprints202109.0031.v1 ◽

2021 ◽

Author(s):

Philippe Rigoard ◽

Amine Ounajim ◽

Lisa Goudman ◽

Benedicte Bouche ◽

Manuel Roulaud ◽

...

Keyword(s):

Back Pain ◽

Peripheral Nerve ◽

Salvage Therapy ◽

Pain Syndrome ◽

Spinal Pain ◽

Added Value ◽

Controlled Study ◽

Field Stimulation ◽

Peripheral Nerve Field Stimulation ◽

Spinal Pain Syndrome

While Spinal Cord Stimulation (SCS) provides satisfaction to almost 2/3 of Persistent Spinal Pain Syndrome-Type 2 (PSPS-T2) patients implanted for refractory chronic back and/or leg pain when not adequately addressed the back pain component, leaves patients in a therapeutic cul-de-sac. Peripheral Nerve field Stimulation (PNfS) has shown interesting results addressing back pain in the same population. Far from placing these two techniques in opposition, we suggest that these approaches could be combined to better treat PSPS-T2 patients. We designed a RCT (CUMPNS), with a 12-month follow-up, to assess the potential added value of PNfS, as a salvage therapy, in PSPS-T2 patients experiencing a “Failed SCS Syndrome” in the back pain component. Fourteen patients were included in this study and randomized into 2 groups (“SCS + PNfS” group/n=6 vs “SCS only” group/n=8). The primary objective of the study was to compare the percentage of back pain surface decrease after 3 months, using a computerized interface to obtain quantitative pain mappings, combined with multi-dimensional SCS outcomes. Back pain surface decreased significantly greater for the ”SCS+PNfS” group (80.2% ± 21.3%) compared to the “SCS only” group (13.2% ± 94.8%) (p=0.012), highlighting the clinical interest of SCS+PNfS, in cases where SCS fails to address back pain.

Download Full-text

An Innovative Case Report Detailing the Successful Treatment of Post-Thoracotomy Syndrome with Peripheral Nerve Field Stimulation

Neuromodulation Technology at the Neural Interface ◽

10.1111/j.1525-1403.2010.00277.x ◽

2010 ◽

Vol 13 (4) ◽

pp. 311-314 ◽

Cited By ~ 9

Author(s):

Tory L. McJunkin ◽

Nicole Berardoni ◽

Paul J. Lynch ◽

Jacob Amrani

Keyword(s):

Case Report ◽

Peripheral Nerve ◽

Successful Treatment ◽

Field Stimulation ◽

Peripheral Nerve Field Stimulation

Download Full-text

Trigemino-Cervical Neuropathic Pain Relieved by Serially Repeated Peripheral Nerve Field Stimulation Without Tolerance: Case Report

Neuromodulation Technology at the Neural Interface ◽

10.1111/ner.12536 ◽

2016 ◽

Vol 20 (4) ◽

pp. 383-385 ◽

Cited By ~ 1

Author(s):

Brian A. Simpson ◽

Ravindra Nannapaneni

Keyword(s):

Neuropathic Pain ◽

Case Report ◽

Peripheral Nerve ◽

Field Stimulation ◽

Peripheral Nerve Field Stimulation

Download Full-text

Peripheral nerve field stimulation successfully manages axial pain after posterior cervical spine surgery: case report

Annals of Palliative Medicine ◽

10.21037/apm-20-978 ◽

2020 ◽

Vol 9 (4) ◽

pp. 21-21

Author(s):

Hiroaki Owada ◽

Masahiko Sumitani ◽

Reo Inoue ◽

Mariko Kawashima ◽

Kazuhiko Ishii ◽

...

Keyword(s):

Case Report ◽

Cervical Spine ◽

Peripheral Nerve ◽

Spine Surgery ◽

Field Stimulation ◽

Cervical Spine Surgery ◽

Axial Pain ◽

Peripheral Nerve Field Stimulation

Download Full-text

The Added Value of Subcutaneous Peripheral Nerve Field Stimulation Combined with SCS, as Salvage Therapy, for Refractory Low Back Pain Component in Persistent Spinal Pain Syndrome Implanted Patients: A Randomized Controlled Study (CUMPNS Study) Based on 3D-Mapping Composite Pain Assessment

Journal of Clinical Medicine ◽

10.3390/jcm10215094 ◽

2021 ◽

Vol 10 (21) ◽

pp. 5094

Author(s):

Philippe Rigoard ◽

Amine Ounajim ◽

Lisa Goudman ◽

Benedicte Bouche ◽

Manuel Roulaud ◽

...

Keyword(s):

Back Pain ◽

Peripheral Nerve ◽

Salvage Therapy ◽

Pain Syndrome ◽

Spinal Pain ◽

Added Value ◽

Controlled Study ◽

Field Stimulation ◽

Peripheral Nerve Field Stimulation ◽

Spinal Pain Syndrome

While Spinal Cord Stimulation (SCS) provides satisfaction to almost 2/3 of Persistent Spinal Pain Syndrome-Type 2 (PSPS-T2) patients implanted for refractory chronic back and/or leg pain, when not adequately addressed the back pain component, leaves patients in a therapeutic cul-de-sac. Peripheral Nerve field Stimulation (PNfS) has shown interesting results addressing back pain in the same population. Far from placing these two techniques in opposition, we suggest that these approaches could be combined to better treat PSPS-T2 patients. We designed a RCT (CUMPNS), with a 12-month follow-up, to assess the potential added value of PNfS, as a salvage therapy, in PSPS-T2 patients experiencing a “Failed SCS Syndrome” in the back pain component. Fourteen patients were included in this study and randomized into 2 groups (“SCS + PNfS” group/n = 6 vs. “SCS only” group/n = 8). The primary objective of the study was to compare the percentage of back pain surface decrease after 3 months, using a computerized interface to obtain quantitative pain mappings, combined with multi-dimensional SCS outcomes. Back pain surface decreased significantly greater for the ”SCS + PNfS” group (80.2% ± 21.3%) compared to the “SCS only” group (13.2% ± 94.8%) (p = 0.012), highlighting the clinical interest of SCS + PNfS, in cases where SCS fails to address back pain.

Download Full-text